Literature DB >> 32683952

Knockout of sulfatase 2 is associated with decreased steatohepatitis and fibrosis in a mouse model of nonalcoholic fatty liver disease.

Tae Hyo Kim1,2, Bubu A Banini1, Faizal Z Asumda3, Nellie A Campbell1, Chunling Hu1, Catherine D Moser1, Abdirashid M Shire1, Shaoshan Han1, Chenchao Ma1, Anuradha Krishnan1, Taofic Mounajjed4, Thomas A White5, Gregory J Gores1, Nathan K LeBrasseur4, Michael R Charlton1, Lewis Rowland Roberts1.   

Abstract

Sulfatase 2 (SULF2) is a heparan sulfate editing enzyme that regulates the milieu of growth factors and cytokines involved in a variety of cellular processes. We used a murine model of diet-induced steatohepatitis to assess the effect of SULF2 downregulation on the development of nonalcoholic steatohepatitis (NASH) and liver fibrosis. Wild-type B6;129 mice (WT) and Sulf2-knockout B6;129P2-SULF2Gt(PST111)Byg mice (Sulf2-KO) were fed a fast-food diet (FFD) rich in saturated fats, cholesterol, and fructose or a standard chow diet (SC) ad libitum for 9 mo. WT mice on FFD showed a threefold increase in hepatic Sulf2 mRNA expression, and a 2.2-fold increase in hepatic SULF2 protein expression compared with WT mice on SC. Knockout of Sulf2 led to a significant decrease in diet-mediated weight gain and dyslipidemia compared with WT mice on FFD. Knockout of Sulf2 also abrogated diet-induced steatohepatitis and hepatic fibrosis compared with WT mice on FFD. Furthermore, expression levels of the profibrogenic receptors TGFβR2 and PDGFRβ were significantly decreased in Sulf2-KO mice compared with WT mice on FFD. Together, our data suggest that knockout of Sulf2 significantly downregulates dyslipidemia, steatohepatitis, and hepatic fibrosis in a diet-induced mouse model of NAFLD, suggesting that targeting of SULF2 signaling may be a potential therapeutic mechanism in NASH.NEW & NOTEWORTHY We report for the first time that in wild-type (WT) mice, fast-food diet (FFD) induced a threefold increase in hepatic Sulf2 mRNA and a 2.2-fold increase in sulfatase 2 (SULF2) protein expression compared with WT mice on standard chow diet (SC). We showed that knockout of SULF2 ameliorates FFD-induced obesity, hyperlipidemia, steatohepatitis, and fibrosis. These data, along with work from other laboratories, suggest that SULF2 may be critical to the ability of the liver to progress to nonalcoholic steatohepatitis and fibrosis in conditions of overnutrition.

Entities:  

Keywords:  SULF2; fast-food diet; liver fibrosis; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; obesity; sulfatase

Mesh:

Substances:

Year:  2020        PMID: 32683952      PMCID: PMC7509257          DOI: 10.1152/ajpgi.00150.2019

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  32 in total

Review 1.  Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E.

Authors:  R W Mahley; Z S Ji
Journal:  J Lipid Res       Date:  1999-01       Impact factor: 5.922

Review 2.  Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.

Authors:  G Vernon; A Baranova; Z M Younossi
Journal:  Aliment Pharmacol Ther       Date:  2011-05-30       Impact factor: 8.171

Review 3.  Translating scientific discovery: the need for preclinical models of nonalcoholic steatohepatitis.

Authors:  Abdul M Oseini; Banumathi K Cole; Danny Issa; Ryan E Feaver; Arun J Sanyal
Journal:  Hepatol Int       Date:  2018-01-03       Impact factor: 6.047

4.  Activation of the transcription factor GLI1 by WNT signaling underlies the role of SULFATASE 2 as a regulator of tissue regeneration.

Authors:  Ikuo Nakamura; Maite G Fernandez-Barrena; Maria C Ortiz-Ruiz; Luciana L Almada; Chunling Hu; Sherine F Elsawa; Lisa D Mills; Paola A Romecin; Kadra H Gulaid; Catherine D Moser; Jing-Jing Han; Anne Vrabel; Eric A Hanse; Nicholas A Akogyeram; Jeffrey H Albrecht; Satdarshan P S Monga; Schuyler O Sanderson; Jesus Prieto; Lewis R Roberts; Martin E Fernandez-Zapico
Journal:  J Biol Chem       Date:  2013-06-05       Impact factor: 5.157

5.  Blockade of IL-6 signaling exacerbates liver injury and suppresses antiapoptotic gene expression in methionine choline-deficient diet-fed db/db mice.

Authors:  Kanji Yamaguchi; Yoshito Itoh; Chihiro Yokomizo; Takeshi Nishimura; Toshihisa Niimi; Atsushi Umemura; Hideki Fujii; Takeshi Okanoue; Toshikazu Yoshikawa
Journal:  Lab Invest       Date:  2011-02-14       Impact factor: 5.662

6.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

7.  A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition.

Authors:  Anuradha Krishnan; Tasduq Sheikh Abdullah; Taofic Mounajjed; Stella Hartono; Andrea McConico; Thomas White; Nathan LeBrasseur; Ian Lanza; Sreekumaran Nair; Gregory Gores; Michael Charlton
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-02-23       Impact factor: 4.052

Review 8.  Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets.

Authors:  Jin-Ping Lai; James R Thompson; Dalbir S Sandhu; Lewis R Roberts
Journal:  Future Oncol       Date:  2008-12       Impact factor: 3.404

9.  Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice.

Authors:  Kristin I Stanford; Joseph R Bishop; Erin M Foley; Jon C Gonzales; Ingrid R Niesman; Joseph L Witztum; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2009-10-01       Impact factor: 14.808

Review 10.  The role of pathway-selective insulin resistance and responsiveness in diabetic dyslipoproteinemia.

Authors:  Xiangdong Wu; Keyang Chen; Kevin Jon Williams
Journal:  Curr Opin Lipidol       Date:  2012-08       Impact factor: 4.616

View more
  2 in total

1.  Sulfatase 2-Induced Cancer-Associated Fibroblasts Promote Hepatocellular Carcinoma Progression via Inhibition of Apoptosis and Induction of Epithelial-to-Mesenchymal Transition.

Authors:  Cong Wang; Chuzhi Shang; Xiaohong Gai; Tao Song; Shaoshan Han; Qingguang Liu; Xin Zheng
Journal:  Front Cell Dev Biol       Date:  2021-04-06

Review 2.  Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders.

Authors:  Alexandros Marios Sofias; Federica De Lorenzi; Quim Peña; Armin Azadkhah Shalmani; Mihael Vucur; Jiong-Wei Wang; Fabian Kiessling; Yang Shi; Lorena Consolino; Gert Storm; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2021-06-15       Impact factor: 15.470

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.